Brokerages Set AdaptHealth Corp. (NASDAQ:AHCO) Target Price at $10.29

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $10.2857.

AHCO has been the subject of several analyst reports. Royal Bank Of Canada decreased their target price on shares of AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a research note on Thursday, August 6th. Wall Street Zen cut shares of AdaptHealth from a “hold” rating to a “sell” rating in a research note on Sunday, August 16th. Truist Financial decreased their price objective on shares of AdaptHealth from $14.00 to $9.00 and set a “buy” rating for the company in a research report on Wednesday, August 5th. Canaccord Genuity Group set a $10.00 price objective on shares of AdaptHealth in a research note on Wednesday, August 5th. Finally, UBS Group dropped their target price on shares of AdaptHealth from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, August 6th.

Insider Activity

In other AdaptHealth news, Director Kenneth Samet acquired 23,500 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was bought at an average cost of $6.38 per share, with a total value of $149,930.00. Following the completion of the transaction, the director directly owned 48,569 shares in the company, valued at approximately $309,870.22. This represents a 93.74% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.95% of the stock is currently owned by insiders.

Institutional Investors Weigh In On AdaptHealth

A number of large investors have recently added to or reduced their stakes in the business. Reinhart Partners LLC. boosted its holdings in shares of AdaptHealth by 10.6% during the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock worth $80,684,000 after buying an additional 773,727 shares during the period. Principal Financial Group Inc. grew its stake in AdaptHealth by 25.1% in the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock valued at $33,133,000 after buying an additional 558,357 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in AdaptHealth by 8.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock valued at $82,353,000 after acquiring an additional 518,274 shares during the period. Lazard Asset Management LLC lifted its position in AdaptHealth by 35.0% during the first quarter. Lazard Asset Management LLC now owns 1,669,454 shares of the company’s stock worth $19,867,000 after acquiring an additional 432,664 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in AdaptHealth by 87.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock worth $10,080,000 after acquiring an additional 395,668 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO opened at $5.82 on Friday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 0.98 and a current ratio of 1.12. The stock has a 50 day moving average price of $7.69 and a 200 day moving average price of $9.73. The stock has a market capitalization of $793.50 million, a PE ratio of -3.40 and a beta of 1.39. AdaptHealth has a 52 week low of $5.21 and a 52 week high of $13.43.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.99) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($1.16). AdaptHealth had a positive return on equity of 3.36% and a negative net margin of 7.07%.The company had revenue of $740.31 million for the quarter, compared to analyst estimates of $846.77 million. During the same period last year, the firm earned $0.10 EPS. The firm’s revenue for the quarter was down 7.5% compared to the same quarter last year.

About AdaptHealth

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, medical supplies and related healthcare services in the United States. The company supports patients who require ongoing care outside of traditional healthcare facilities and works with physicians, hospitals, insurers and other referral sources to coordinate equipment delivery, setup and clinical support.

AdaptHealth’s offerings include respiratory equipment such as oxygen systems, ventilators and continuous positive airway pressure (CPAP) devices; diabetes supplies; sleep therapy products; mobility equipment; wheelchairs; wound-care products; and other home medical equipment and disposable supplies.